Cargando…
Oligometastatic Disease in Non-Small-Cell Lung Cancer: An Update
SIMPLE SUMMARY: Approximately 7–50% of patients with non-small-cell lung cancer (NSCLC) develop oligometastases, which are new tumors found in another part of the body, arising from cancer cells of the original tumor that have travelled through the body. In recent years, these patients have been inc...
Autores principales: | Chen, Yi-Hsing, Ho, Ue-Cheung, Kuo, Lu-Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909159/ https://www.ncbi.nlm.nih.gov/pubmed/35267658 http://dx.doi.org/10.3390/cancers14051350 |
Ejemplares similares
-
Classifying Oligometastatic Non-Small Cell Lung Cancer
por: Blumenthaler, Alisa N., et al.
Publicado: (2021) -
Oligometastatic non-small cell lung cancer: Current management
por: Román-Jobacho, Alicia, et al.
Publicado: (2021) -
The Role of Surgery for Oligometastatic Non-Small Cell Lung Cancer
por: Euhus, Caleb J., et al.
Publicado: (2022) -
Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer
por: Wujanto, Caryn, et al.
Publicado: (2019) -
Genomic Characteristics and the Potential Clinical Implications in Oligometastatic Non–Small Cell Lung Cancer
por: Liao, Rongxin, et al.
Publicado: (2023)